aser therapy for the treatment of chronic periodontitis

Completed

• Conditions: Moderate to advanced chronic periodontitis; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12607000129482
• Lead Sponsor: Department of Oral Sciences, School of Dentistry, University of Otago, New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-02-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

All participants will have a minimum 16 teeth (4 per quadrant) and a diagnosis of moderate or advanced chronic periodontitis defined as PD =5mm, attachment loss of =2mm and bleeding on probing in 6 or more sites distributed throughout the mouth. They will be in good general health, and will have received no periodontal treatment within the previous 6 months. All patients must comprehend the visual analogue scale (VAS) and will sign informed consent forms.

Exclusion Criteria

Patients will be excluded from the study if they suffer from systemic diseases which could influence the outcome of therapy; require antibiotic coverage prior to dental treatment; use of medications such as antibiotics, steroids and anti-inflammatories in the 3 months prior to treatment; are pregnant; or are heavy smokers ( = 10 cigarettes per day).

Study & Design

• Study Type: Interventional
• Study Design: Not specified